Temporal Course of Vascular Response After Fluoropolymer Paclitaxel-Eluting Stent Implantation for Femoropopliteal Artery Lesions
Author:
Affiliation:
1. Department of Cardiology, Kokura Memorial Hospital
2. Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science
Publisher
Japanese Circulation Society
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://www.jstage.jst.go.jp/article/circj/85/12/85_CJ-20-1200/_pdf
Reference20 articles.
1. 1. Müller-Hülsbeck S, Keirse K, Zeller T, Schroë H, Diaz-Cartelle J. Twelve-month results from the MAJESTIC trial of the eluvia paclitaxel-eluting stent for treatment of obstructive femoropopliteal disease. J Endovasc Ther 2016; 23: 701–707.
2. 2. Hou D, Huibregtse BA, Eppihimer M, Stoffregen W, Kocur G, Hitzman C, et al. Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: Pharmacokinetics and vascular biology responses in a porcine iliofemoral model. EuroIntervention 2016; 12: 790–797.
3. 3. Gasior P, Cheng Y, Valencia AF, McGregor J, Conditt GB, Kaluza GL, et al. Impact of fluoropolymer-based paclitaxel delivery on neointimal proliferation and vascular healing: A comparative peripheral drug-eluting stent study in the familial hypercholesterolemic swine model of femoral restenosis. Circ Cardiovasc Interv 2017; 10: e004450.
4. 4. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, et al; IMPERIAL investigators. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial. Lancet 2018; 392: 1541–1551.
5. 5. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol 2015; 10: 931–941.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3